Response to comments on the Scientific Opinion of the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) on the scientific substantiation of a health claim related[...]

Following a request from the European Commission, EFSA was asked to review the scientific comments received on the Scientific Opinion of the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) on the scientific substantiation of a health claim related to calcium sulphate and reduction in body weight pursuant to Article 13.5 of Regulation (EC) No 1924/2006. Comments originating from the applicant (Mediconomics APS) were submitted to EFSA via the European Commission Services. EFSA has reviewed the comments with the contribution of the chair of the NDA Working Group on Claims, and the chair of the NDA Panel. In its opinion adopted on 27 August 2025 the EFSA NDA Panel concluded that a cause and effect relationship has not been established between the consumption of calcium sulphate and a reduction in body weight under the proposed conditions of use. The comments received do not require any change in the conclusions of the NDA Panel.